Synocrom 1x 2,0 ml Sinclair Pharma GmbH • Die kontrollierte klinische Studie

• Die kontrollierte klinische Studie mit Synvisc-One zeigte eine vergleichbare Anzahl und Art der Nebenwirkungen zwischen der Patientengruppe

Rötungen

HYADD® 4 for intra-articular injection

The product must not be re-sterilized as this may damage or alter the product

Synocrom 1x 2,0 ml Sinclair Pharma GmbH • Die kontrollierte klinische StudieInstructions for use of Synocrom 1. Purpose and Indications This product is a medical device intended for use in humans and is injected into synovial joints (knee, hip, ankle, and shoulder) to restore the natural viscoelastic properties of the synovial fluid (viscosupplementation). It is indicated for the treatment of pain and restricted mobility due to degenerative or traumatic changes in synovial joints (osteoarthritis). 2. Description The product